Patients with known human immunodeficiency virus (HIV) or hepatitis B or C are excluded
Previously known infection with human immunodeficiency virus (HIV); or hepatitis B or hepatitis C infection.
History of human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C.
Known history of human immunodeficiency virus infection (HIV) or hepatitis C or active hepatitis B infection, unless the patient was diagnosed > years prior to enrollment and no evidence of active liver disease.
EXCLUSION CRITERIA FOR SECOND-LINE THERAPY: Active severe infection, or known chronic infection with human immunodeficiency virus (HIV) or hepatitis B virus
EXCLUSION CRITERIA FOR THIRD-LINE THERAPY: Active severe infection, or known chronic infection with human immunodeficiency virus (HIV) or hepatitis B virus
Known active hepatitis B infection, active hepatitis C infection or known human immunodeficiency virus (HIV) carrier
Active hepatitis or human immunodeficiency virus infection
Patients with human immunodeficiency virus (HIV) infection, or active hepatitis B or C virus infection will be excluded
PHASE II EXCLUSION CRITERIA: Patients with human immunodeficiency virus (HIV) infection, or active hepatitis B or C virus infection will be excluded
Active human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C infection.
Known chronic infection with human immunodeficiency virus (HIV) or viral hepatitis
Has known human immunodeficiency virus (HIV) and/or Hepatitis B or C infection(s).
Known infection with Human Immunodeficiency Virus (HIV), and/or active infection with hepatitis B, or hepatitis C.
Known history of human immunodeficiency virus (HIV), hepatitis B, or hepatitis C infection or known history of tuberculosis
Have a known human immunodeficiency virus (HIV) infection or known activated/reactivated hepatitis A, B, or C.
Active human immunodeficiency virus (HIV) or hepatitis B or C infection
Known human immunodeficiency virus (HIV) or known hepatitis C virus (HCV) infection or active hepatitis B.
Known Human Immunodeficiency Virus (HIV) infection and/or active Hepatitis B or Hepatitis C infection
Patients must not have known human immunodeficiency virus (HIV) infection or active hepatitis B or C infections
Known active human immunodeficiency virus (HIV) or hepatitis B or C infection
No human immunodeficiency virus (HIV) infection or active hepatitis B or C.
Known active hepatitis B (HBV) or hepatitis C (HCV) infection or known human immunodeficiency virus (HIV) infection.
Patients must not have known human immunodeficiency virus (HIV) infection, active hepatitis B and/or hepatitis C.
Patients with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
Known infection caused by human immunodeficiency virus (HIV) or active hepatitis B or C
Patients with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
Patients with a known chronic immunocompromised state, human immunodeficiency virus (HIV) infection, or active hepatitis B or C infection
Acute hepatitis or known human immunodeficiency virus (HIV)
CRITERIA FOR SCREENING: Known active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection
Known to have acute or chronic active hepatitis B infection, hepatitis C infection, or known to have human immunodeficiency virus (HIV) infection
Known hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.
Known human immunodeficiency virus (HIV) or active hepatitis A, B, or C
History of human immunodeficiency virus (HIV) infection or active hepatitis B or C
Known human immunodeficiency virus (HIV), active hepatitis A, or hepatitis B or C infection
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Known active infection with human immunodeficiency virus (HIV), hepatitis B or C viruses (screening not required)
No human immunodeficiency virus (HIV) infection or active hepatitis B or C
Patients with known human immunodeficiency virus (HIV) infection or hepatitis
Known history of human immunodeficiency virus (HIV) or active hepatitis C
Known active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection
Known human immunodeficiency virus (HIV) infection or active hepatitis A, B or C
Has a known history of human immunodeficiency virus (HIV) (HIV/ antibodies), hepatitis B, or hepatitis C infection
DONOR: Active human immunodeficiency virus (HIV) or hepatitis B or C infection
Be on immunosuppressive therapy or have human immunodeficiency virus (HIV) infection or active hepatitis B or C
Patients with known hepatitis B or C or human immunodeficiency virus (HIV) infection
Known active hepatitis B infection, known history of hepatitis C or human immunodeficiency virus (HIV) infection
Have a known history of human immunodeficiency virus (HIV) (HIV / antibodies), hepatitis B, or hepatitis C infection
Active hepatitis B or hepatitis C or known human immunodeficiency virus (HIV) infection
Known human immunodeficiency virus (HIV) or hepatitis C
Active and uncontrolled infection including but not limited to known infection with human immunodeficiency virus (HIV), active hepatitis B, or hepatitis C
Human immunodeficiency virus (HIV) infection, active hepatitis B or C infection, or evidence of liver cirrhosis
Hepatitis C infection, chronic infection with hepatitis B, infection with human immunodeficiency virus (HIV), or evidence of hepatic insufficiency
A known history of human immunodeficiency virus (HIV) seropositivity, hepatitis C virus, acute or chronic active hepatitis B infection, or other serious chronic infection requiring ongoing treatment
Known infection with human immunodeficiency virus (HIV), hepatitis B or C
Known infection with human immunodeficiency virus (HIV), hepatitis B or C
History of human immunodeficiency virus (HIV), or known active hepatitis B or C infection.
No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
Known active infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C.
Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C.
Known hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.
No infection with human immunodeficiency virus (HIV) and no known history of hepatitis B or hepatitis C virus indicating acute or chronic infection or active tuberculosis (TB)
Uncontrolled infection with human immunodeficiency virus (HIV) or chronic hepatitis B or C.
Patients with known active hepatitis B or C or human immunodeficiency virus (HIV) infection or with history of tuberculosis
Known chronic hepatitis B or C, or human immunodeficiency virus (HIV) infection
Known active human immunodeficiency virus (HIV) or hepatitis A, B, or C virus infection
Patients with a known history of human immunodeficiency virus (HIV) infection or active hepatitis B or hepatitis C
Known active hepatitis B infection, known active hepatitis C infection, or known human immunodeficiency virus (HIV) carrier
Known human immunodeficiency virus (HIV) infection or known history of active hepatitis B or C infection
Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C.
Has a known Human Immunodeficiency Virus (HIV), or a known, active Hepatitis B (HBV), or a known, active Hepatitis C (HCV) infection.
Known human immunodeficiency virus (HIV), or Hepatitis B or C.
Patients with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
Known human immunodeficiency virus (HIV) or known active hepatitis B or hepatitis C infection for participants not receiving obinutuzumab pretreatment
Known Human Immunodeficiency Virus (HIV) infection or active hepatitis A, B, or C
Known active or chronic hepatitis B or C or human immunodeficiency virus (HIV)
Known active hepatitis B or C, or human immunodeficiency virus (HIV) infection
History of human immunodeficiency virus (HIV) infection, active hepatitis B (chronic or acute), or hepatitis C infection
Known history of human immunodeficiency virus (HIV), or known active hepatitis A, B, or C infection;
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B
Active infection with hepatitis B or C or human immunodeficiency virus (HIV)
Known human immunodeficiency virus (HIV), active hepatitis A, or hepatitis B or C infection
History of hepatitis B or C, human immunodeficiency virus (HIV), tuberculosis or a chronic infection of any type
Known human immunodeficiency virus (HIV) infection, active chronic hepatitis B or C, or life-threatening illnesses unrelated to cancer.
Known active human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C infection on antiviral treatment
Active infection with hepatitis B or C or human immunodeficiency virus (HIV)
Known history of human immunodeficiency virus (HIV) and/or active Hepatitis B or C infections
Known infection with human immunodeficiency virus (HIV), hepatitis B or C
Known hepatitis B or C virus, or human immunodeficiency virus (HIV) infection
Known history of human immunodeficiency virus (HIV), active Hepatitis B or C
Clinically active infection as judged by the treating investigator (? Grade  by CTCAE v) including known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Subjects with a known history of hepatitis B or C or human immunodeficiency (HIV) infection.
Known hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection
Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C.
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Known human immunodeficiency virus (HIV), hepatitis B and hepatitis C infection
Known active uncontrolled human immunodeficiency virus (HIV) or hepatitis C infection
Known human immunodeficiency virus (HIV) or active hepatitis B or C viral infection
Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C.
Known human immunodeficiency virus (HIV) or active hepatitis B or C infection
Active human immunodeficiency virus (HIV), hepatitis A, B or C infection
No additional screening intended for human immunodeficiency virus (HIV) or hepatitis infection
Known chronic infection with human immunodeficiency virus (HIV) or viral hepatitis
Known human immunodeficiency virus (HIV) infection, hepatitis B or Hepatitis C infection
No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
Active hepatitis or human immunodeficiency virus (HIV) infection
Known Human Immunodeficiency Virus (HIV) infection, chronic hepatitis B or C (unless associated with hepatocellular cancer)
Known Human immunodeficiency virus (HIV) infection or active hepatitis A, B, or C
Patients with known active viral hepatitis or known human immunodeficiency virus (HIV) infection
No known human immunodeficiency virus (HIV) infection or chronic hepatitis B or hepatitis C infection
Known history of Human Immunodeficiency Virus (HIV) infection or chronic hepatitis B or C
Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C.
Known active infection with human immunodeficiency virus (HIV), hepatitis B or C
Known human immunodeficiency virus (HIV) and/or active Hepatitis B or C infections
Also, known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Has known, previously diagnosed human immunodeficiency virus infection or active chronic hepatitis B or C.
Active hepatitis B infection, active hepatitis C infection or known human immunodeficiency virus (HIV) carrier
Patients with known human immunodeficiency virus (HIV) or Hepatitis B or C (active, previously treated or both)
Patients with known human immunodeficiency virus (HIV), or known active hepatitis B or C infections
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Patients with known human immunodeficiency virus (HIV) or hepatitis B or C
Known human immunodeficiency virus (HIV) or hepatitis B or C infection
Patients with active hepatitis B or C infections or a history of human immunodeficiency virus (HIV) infection
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C; must test during screening if history is not known
Previously known infection with human immunodeficiency virus (HIV); or, hepatitis B or C requiring treatment;
Known and actively treated infection with human immunodeficiency virus (HIV), hepatitis B or C
Known human immunodeficiency virus (HIV) or active hepatitis B or C infection
Active severe infection, or known chronic infection with human immunodeficiency virus (HIV) or hepatitis B virus
Known active human immunodeficiency virus (HIV) infection, hepatitis B or C
Known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
Active hepatitis B infection, active hepatitis C infection or known human immunodeficiency virus (HIV) carrier
Patient with known historical or active infection with human immunodeficiency virus (HIV), hepatitis B or hepatitis C
Acute hepatitis, known human immunodeficiency virus (HIV), or active uncontrolled infection
Subjects who are known to have a history of or active human immunodeficiency virus (HIV) or active hepatitis B and/or C
Have known hepatitis B or C, or human immunodeficiency virus infection
No infection with human immunodeficiency virus (HIV) and no active infection with hepatitis B and no active or chronic infection with hepatitis C
Known active hepatitis B, hepatitis C or Human Immunodeficiency Virus (HIV) infection.
Active Human Immunodeficiency Virus (HIV) or hepatitis B or C infection
Subjects may not have known human immunodeficiency virus (HIV), active hepatitis A, or hepatitis B or C infection
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Known or suspected human immunodeficiency virus (HIV) or hepatitis A(acute), B or C infection
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
Patients with clinically significant infection, including known human immunodeficiency virus (HIV), human herpesvirus- (HHV-), hepatitis C infection, or known hepatitis B surface antigen positivity are not eligible
Patients with known human immunodeficiency virus (HIV) infection or viral hepatitis
No known history of human immunodeficiency virus (HIV) or active hepatitis B or C
Have a known history of human immunodeficiency virus (HIV) (HIV / antibodies), hepatitis B, or hepatitis C infection
History of known active infection with human immunodeficiency virus (HIV), hepatitis B or hepatitis C
History of known active infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
Known history of or known active infection with human immunodeficiency virus (HIV), hepatitis B or hepatitis C
Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C
Known active infection with human immunodeficiency virus (HIV), hepatitis A, B, or C
Known active hepatitis B/C or HIV (human immunodeficiency virus) infection
Known history of human immunodeficiency virus (HIV), or active Hepatitis B or C.
Known human immunodeficiency virus (HIV) seropositive or known hepatitis B or hepatitis C infection.
Is previously diagnosed human immunodeficiency virus (HIV) infection or active hepatitis B or C.
Human immunodeficiency virus (HIV), or active hepatitis B or C infection
